| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052630665 |
| P356 | DOI | 10.1007/S11934-014-0415-4 |
| P698 | PubMed publication ID | 24740275 |
| P50 | author | Wayne J G Hellstrom | Q89786974 |
| Premsant Sangkum | Q125134122 | ||
| P2093 | author name string | Gregory C Mitchell | |
| Ronny B W Tan | |||
| P2860 | cites work | A new concept in the treatment of Peyronie's disease | Q79534806 |
| Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study | Q80974595 | ||
| Peyronie's disease | Q82305241 | ||
| Tissue engineering for penile surgery: comparative study of noncellular and cell-seeded synthetic grafts for tunica albuginea replacement | Q82828221 | ||
| Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study | Q83039500 | ||
| Surgical option for the correction of Peyronie's disease: an autologous tissue-engineered endothelialized graft | Q84478190 | ||
| Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants | Q27021546 | ||
| Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study | Q30011016 | ||
| Radiotherapeutic treatment of Peyronie s disease | Q33508899 | ||
| Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease | Q33642378 | ||
| Radiobiological mechanisms of anti-inflammatory radiotherapy | Q33704440 | ||
| Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study. | Q34132004 | ||
| Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. | Q34186033 | ||
| Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study | Q34403964 | ||
| Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease | Q34534562 | ||
| Medical management of Peyronie's disease | Q34869735 | ||
| Injectable collagenase clostridium histolyticum for Dupuytren's contracture | Q35000980 | ||
| A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease. | Q35009905 | ||
| The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. | Q35185993 | ||
| Summary of the recommendations on sexual dysfunctions in men. | Q36372482 | ||
| Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease | Q36395176 | ||
| Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix | Q36526721 | ||
| Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease | Q36648279 | ||
| Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial | Q36734258 | ||
| Pharmacological Management of Peyronie's Disease | Q36757584 | ||
| Peyronie's disease intervention trials: methodological challenges and issues | Q37366843 | ||
| Diagnostic and therapeutic applications of iontophoresis | Q37618810 | ||
| Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy | Q37704966 | ||
| Trauma, gender reassignment, and penile augmentation. | Q37730215 | ||
| The management of Peyronie's disease: evidence-based 2010 guidelines | Q37760270 | ||
| The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes | Q37842789 | ||
| Nonsurgical interventions for Peyronie disease: 2011 update | Q37847020 | ||
| Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options | Q37853180 | ||
| Peyronie's disease: review of nonsurgical treatment options | Q37881322 | ||
| Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies | Q37981709 | ||
| Radiation therapy in Peyronie's disease. | Q38025221 | ||
| Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies | Q38078696 | ||
| Uro-dermatological problems of a construction worker: paraaminobenzoic acid as a systemic photosensitizer | Q39207757 | ||
| Conservative treatment of Peyronie's disease: colchicine vs. colchicine plus vitamin E | Q39285920 | ||
| Outcome analysis for conservative management of Peyronie's disease | Q39352017 | ||
| A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. | Q39383271 | ||
| Treatment of Peyronie's disease with local interferon-alpha 2b. | Q39419090 | ||
| Is colchicine effective in Peyronie's disease? A pilot study | Q39482557 | ||
| Steroid injection therapy for Peyronie's disease: a 10-year summary and review of 38 cases | Q40073357 | ||
| The effects of colchicine on a Peyronie's-like condition in an animal model | Q41665815 | ||
| Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases. | Q41909374 | ||
| Pentoxifylline treatment and penile calcifications in men with Peyronie's disease. | Q42141074 | ||
| Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial | Q43003227 | ||
| Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report | Q43669319 | ||
| An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. | Q43758174 | ||
| Antifibrotic role of inducible nitric oxide synthase | Q43920633 | ||
| Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease | Q43993189 | ||
| Experience with intraplaque injection of verapamil for Peyronie's disease | Q44072672 | ||
| Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea | Q44222785 | ||
| Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma | Q44413643 | ||
| Peyronie’s Disease: Results with Dermo-Jet Injection of Dexamethasone | Q44792781 | ||
| The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study | Q44934972 | ||
| Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial | Q45803932 | ||
| Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A prospective, randomized, double-blind placebo-controlled study. | Q46005434 | ||
| Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study | Q46130680 | ||
| Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease | Q46153965 | ||
| Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study | Q46329766 | ||
| Urologist practice patterns in the management of Peyronie's disease: a nationwide survey | Q46879782 | ||
| Francois de LaPeyronie (1978-1747): the man and the disease he described. | Q48854242 | ||
| Intralesional verapamil injection for the treatment of Peyronie's disease. | Q51133527 | ||
| Treatment of Peyronie's disease by extracorporeal shockwave therapy: evaluation of our preliminary results. | Q51427852 | ||
| The chronology of depression and distress in men with Peyronie's disease. | Q51889728 | ||
| Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases. | Q53118860 | ||
| A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. | Q53193957 | ||
| Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. | Q53230701 | ||
| Tamoxifen versus placebo in the treatment of Peyronie's disease. | Q55033437 | ||
| The use of skeletal traction in the treatment of severe primary Dupuytren's disease | Q58748273 | ||
| ORIGINAL RESEARCH—PEYRONIE'S DISEASE: Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective Study | Q62660594 | ||
| Vascular lesions following radiation | Q68422141 | ||
| The Treatment of Peyronie’s Disease by Iontophoresis Of C 21 Esterified Glucocorticoids | Q72222253 | ||
| Extensive corporeal fibrosis after penile irradiation | Q72394853 | ||
| The continuous elongation technique for severe Dupuytren's disease. A biochemical mechanism | Q72814339 | ||
| Peyronie's disease; cortisone-hyaluronidase-hydrocortisone therapy | Q73549687 | ||
| Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction | Q73708956 | ||
| A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression | Q73754194 | ||
| Peyronie's disease-the Plymouth experience of extracorporeal shockwave treatment | Q74040788 | ||
| Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study | Q74544970 | ||
| Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study | Q76372661 | ||
| A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease | Q78144121 | ||
| Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba) | Q78663002 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 415 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Current urology reports | Q26853936 |
| P1476 | title | Update on medical management of Peyronie's disease | |
| P478 | volume | 15 |
| Q38257165 | 2013-2014 updates in Peyronie's disease management |
| Q35818220 | An Analysis of Case Logs From American Urologists in the Treatment of Peyronie's Disease. |
| Q26744350 | Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence |
| Q42353500 | Collagenase clostridium hystolyticum in the management of Peyronie's disease |
| Q26746136 | Penile traction therapy for Peyronie's disease-what's the evidence? |
| Q90223509 | Scrotal septum detachment during penile plication to compensate for loss of penile length compared with conventional surgical technique |
| Q88016239 | Self-reported Clinical Meaningfulness Early in the Treatment Course Predicts Objective Outcomes in Men Undergoing Collagenase Clostridium histolyticum Injections for Peyronie Disease |
| Q38920333 | Stem cell therapy for the treatment of Peyronie's disease |
| Q40066719 | Use of a lyophilized bovine pericardium graft to repair tunical defect in patients with Peyronie's disease: experience in a clinical setting |
Search more.